Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Risa Ishii"'
Autor:
Toshiro Niwa, Risa Ishii
Publikováno v:
Drug Metabolism and Bioanalysis Letters. 15:75-80
Objective: The mechanism-based inhibition of macrolide antibiotics, such as erythromycin and clarithromycin, and piperine on testosterone 6β-hydroxylation activities by cytochrome P450 (CYP) 3A4, polymorphically expressed CYP3A5, and fetal CYP3A7 we
Publikováno v:
Biologicalpharmaceutical bulletin. 44(4)
The inhibitory and stimulatory effects of steroid hormones and related compounds on the hydroxylation activity at the 6β-position of two steroid hormones, progesterone and testosterone, by CYP3A4, polymorphically expressed CYP3A5, and fetal CYP3A7 w
Autor:
Haruki Nishizawa, Risa Ishii, Yoshiko Sakabe, Yutaka Hirota, Eiji Nishio, Kazuhiko Tsukada, Mayuko Ito, Takuma Fujii, Tomoko Kato
Publikováno v:
JAPANESE JOURNAL OF GYNECOLOGIC AND OBSTETRIC ENDOSCOPY. 30:404-408
Autor:
Shuko Oe, Yasuhiro Udagawa, Kiyoshi Hasegawa, Yoichi Kobayashi, Risa Ishii, Yutaka Torii, Rina Kato, Akiko Owaki, Hiroshi Hirasawa
Publikováno v:
OncoTargets and therapy
OncoTargets and Therapy, Vol 2013, Iss default, Pp 1065-1071 (2013)
OncoTargets and Therapy, Vol 2013, Iss default, Pp 1065-1071 (2013)
Rina Kato,1 Kiyoshi Hasegawa,1 Risa Ishii,1 Akiko Owaki,1 Yutaka Torii,1 Shuko Oe,1 Hiroshi Hirasawa,2 Yoichi Kobayashi,3 Yasuhiro Udagawa1 1Department of Obstetrics and Gynecology, Fujita Health University School of Medicine, Toyoake, Japan; 2Depart
Autor:
Yasuhiro Udagawa, Makoto Kuroda, Shuko Oe, Kiyoshi Hasegawa, Ryoko Ichikawa, Yoichi Kobayashi, Risa Ishii, Rina Kato
Publikováno v:
International Journal of Clinical Oncology. 16:751-758
Alveolar soft part sarcoma (ASPS) that originates from the uterine cervix is extremely rare, with only thirteen cases reported. The participation of the ASPL-TFE3 chimeric gene, translocation (X; 17) (p11; q25), has been demonstrated in ASPS. Here, w
Publikováno v:
Archives of gynecology and obstetrics. 284(6)
COX-2 is highly expressed in endometrial cancers, suggesting that a selective COX-2 inhibitor could be valuable for treating endometrial cancers that overexpress COX-2. In this study, we investigated the anti-tumor effects of the selective COX-2 inhi
Autor:
Rina Kato, Kiyoshi Hasegawa, Risa Ishii, Akiko Owaki, Yutaka Torii, Shuko Oe, Hiroshi Hirasawa, Yoichi Kobayashi, Yasuhiro Udagawa
Publikováno v:
OncoTargets & Therapy; 2013, Vol. 6, p1065-1071, 7p